CT-2584
CT-2584 is an anticancer agent that inhibits phospholipid signaling and kills tumor cells through the production of reactive oxygen intermediates. CT-2584 reduces NKEF-B expression in several tumor cell types. CT-2584 reduced tumor growth in SCID mice by causing shunting of ab initio phospholipid biosynthesis from phosphatidylcholine (PC) to phosphatidylinositol (PI) via PA.
Product Specifications
CAS Number
166981-13-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
533.79
Molecular Formula
C30H55N5O3
Notes
Research use only, not for human use.
Receptor
Reactive Oxygen Species
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6176874-01 0.1 mL
NR4A2 (Nuclear Receptor Subfamily 4, Group A, Member 2, HZF-3, NOT, NURR1, RNR1, TINUR) (FITC)
Sign In for Pricing
View Details MBS6176874-02 5x 0.1 mL
NR4A2 (Nuclear Receptor Subfamily 4, Group A, Member 2, HZF-3, NOT, NURR1, RNR1, TINUR) (FITC)
Sign In for Pricing
View Details 
